Mesenchymal Stem Cell-Mediated Mitochondrial Transfer: a Therapeutic Approach for Ischemic Stroke.
Meng LuJindong GuoBowen WuYuhui ZhouMishan WuMaryam FarzanehSeyed Esmaeil KhoshnamPublished in: Translational stroke research (2020)
Stroke is the leading cause of death and adult disability worldwide. Mitochondrial dysfunction is one of the hallmarks of stroke-induced neuronal death, and maintaining mitochondrial function is essential in cell survival and neurological progress following ischemic stroke. Stem cell-mediated mitochondrial transfer represents an emerging therapeutic approach for ischemic stroke. Accumulating evidence suggests that mesenchymal stem cells (MSCs) can directly transfer healthy mitochondria to damaged cells, and rescue mitochondrial damage-provoked tissue degeneration. This review summarizes the research on MSCs-mediated mitochondrial transfer as a therapeutic strategy against ischemic stroke.
Keyphrases
- mesenchymal stem cells
- atrial fibrillation
- oxidative stress
- umbilical cord
- stem cells
- induced apoptosis
- bone marrow
- diabetic rats
- multiple sclerosis
- cerebral ischemia
- cell therapy
- high glucose
- young adults
- electron transfer
- brain injury
- drug induced
- endoplasmic reticulum
- cell proliferation
- signaling pathway
- reactive oxygen species